These findings contradict Zhou et al.’s finding of reported SPRY4 promoter hypermethylation in a limited number of CRC patients [13], where genomic coordinates or approximations of where DNA methylation was tested in the SPRY4 promoter region were not provided. The gene discussed is SPRY4; the disease is colorectal carcinoma.